Madrigal Pharmaceuticals
MDGL
MDGL
84 hedge funds and large institutions have $119M invested in Madrigal Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 34 increasing their positions, 25 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
41% less call options, than puts
Call options by funds: $412K | Put options by funds: $701K
72% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 18
Holders
84
Holding in Top 10
1
Calls
$412K
Puts
$701K
Top Buyers
| 1 | +$3.48M | |
| 2 | +$615K | |
| 3 | +$554K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$377K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$333K |
Top Sellers
| 1 | -$892K | |
| 2 | -$836K | |
| 3 | -$533K | |
| 4 |
Bank of New York Mellon
New York
|
-$263K |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$249K |